Venoarterial extracorporeal membrane oxygenation combined with hemoperfusion for acute myocardial infarction complicated by cardiogenic shock: the pilot study, a single-center randomized controlled trial

Cardiology Plus · Published 2026-07-16 · DOI 10.1097/cp9.0000000000000164

Free full text

Authors (9)

Jingyan Hao, Qin Yang, Wenhua Lin, Shifu Wang, Wei Wang, Shan Guo, Zhuoxian Zhao, Ying Zhou, Fei Dong

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Hao, J., Yang, Q., Lin, W., et al. (2026). Venoarterial extracorporeal membrane oxygenation combined with hemoperfusion for acute myocardial infarction complicated by cardiogenic shock: the pilot study, a single-center randomized controlled trial. Cardiology Plus. https://doi.org/10.1097/cp9.0000000000000164

Related articles

• The role of myeloperoxidase as a biomarker in atherosclerotic cardiovascular disease · Cardiology Plus · 2024 · Same journal
• The safety and efficacy of the microaxial SynFlow 3.0 flow pump system for patients undergoing high-risk percutaneous coronary intervention · Cardiology Plus · 2025 · Same journal
• Single-cell sequencing and machine learning identify endoplasmic reticulum stress as a mechanism and therapeutic target in heart failure · Cardiology Plus · 2026 · Same journal
• Cardio-oncology training: a look under the hood · Cardiology Plus · 2025 · Same journal
• Histological validation of artificial intelligence–driven automatic plaque characterization in coronary OCT: a head-to-head comparison with clinicians · Cardiology Plus · 2025 · Same journal
• New insights into atherosclerotic cardiovascular disease through the lens of metabolism: expanding our approach · Cardiology Plus · 2025 · Same journal
• Rats subject to extracorporeal membrane oxygenation have improved cardiac function following anticoagulation and reversal with factor IXa aptamer-antidote oligonucleotide pair · Cardiology Plus · 2025 · Same journal
• Cardiac light-chain amyloidosis: a clinical update · Cardiology Plus · 2026 · Same journal
• Cepharanthine aggravated atherosclerosis and liver injury in Apoe −/− and Ldlr −/− mice · Cardiology Plus · 2025 · Same journal
• Doxorubicin-induced cardiotoxicity: mechanisms, surveillance, and prevention strategies · Cardiology Plus · 2026 · Same journal